ACR 0.00% 6.0¢ acrux limited

lilly to acquire global license to axiron, page-5

  1. 366 Posts.
    Looks like very good times ahead. So many psychological barriers overcome with this deal too - ACR now has cashflow, and another $50m to top up the R&D budget which was down from $30m to about $10m as I understand.

    Great business, great model. Conservative and hardworking. Plenty more products in the pipeline (though of course axiron is the flagship.

    Good luck to all.
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.